trial

Salsalate for Insulin Resistance in Schizophrenia

NCTId NCT01182727
as of 2026-07-01
at a glance
· Completed
Enrollment 13 (actual)
Primary completion 2011-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Completed
Enrollment
13 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2010-08
Primary completion
2011-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Sponsors

Investigators

1
Robert W Buchanan, MDPrincipal Investigator

Sites

2 total
Baltimore, United StatesBaltimore, United States

Facts & assertions

4 sourced
Enrollment
13
Phase
NA
Primary Completion Date
2011-11
Status
COMPLETED
relationships
The graph out of here
drug
indication
indication
indication
investigator